HilleVax, Inc. - Common Stock
HilleVax, Inc. - Common Stock
Share · US43157M1027 · HLVX (XNAS)
Overview
No Price
16.09.2025 22:13
1 day
-
1 week
-
1 month
-
3 months
-
6 months
-
Year to date
-
1 year
-
2 years
-
3 years
-
4 years
-
5 years
-
10 years
-
20 years
-
Max
-
Analyst Grade Summary
gauge-img
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
0
1
5
0
0
Current Prices from HilleVax, Inc. - Common Stock
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
HLVX
USD
16.09.2025 22:13
2,10 USD
0,00 USD
Share Float & Liquidity
Free Float 45,36 %
Shares Float 22,74 M
Shares Outstanding 50,14 M
Company Profile for HilleVax, Inc. - Common Stock Share
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

Company Data

Name HilleVax, Inc. - Common Stock
Company HilleVax, Inc.
Symbol HLVX
Website https://www.hillevax.com
Primary Exchange XNAS NASDAQ
ISIN US43157M1027
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Robert M. Hershberg
Market Capitalization 104 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 75 State Street, 02109 Boston
IPO Date 2022-04-29

Ticker Symbols

Name Symbol
NASDAQ HLVX
More Shares
Investors who hold HilleVax, Inc. - Common Stock also have the following shares in their portfolio:
BARCLAYS 22/28 FLR MTN
BARCLAYS 22/28 FLR MTN Bond
SPDR SSGA My2031 Corporate Bond ETF
SPDR SSGA My2031 Corporate Bond ETF ETF
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025